A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced or Metastatic Solid Tumors|Ovarian Cancer|Non-small Cell Lung Cancer|Breast Cancer
Interventions: DRUG: NC762
Sponsor: NextCure, Inc.